Name: UMIN ID:
Unique ID issued by UMIN | UMIN000039049 |
---|---|
Receipt number | R000044529 |
Scientific Title | Phase II study of VAC2.2(vincristine, actinomycin-D, cyclophosphamide)/ VA(vincristine, actinomycin-D) therapy for patients with newly diagnosed low-risk subset B rhabdomyosarcoma. |
Date of disclosure of the study information | 2020/01/10 |
Last modified on | 2020/01/03 13:29:01 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/01/03 20:02:02 |